ADD-What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?

ADD-What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?

163 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
In this weeks video, Brian G.M. Durie explains that even though Revlimid and Pomalyst may reduce white blood cell counts, they do not permanently affect the bone marrow.

BOTTOM LINE:
Revlimid and Pomalyst may reduce white blood cell counts, so stop or adjust dosing accordingly.
Up Next Autoplay